Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease.The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode ...

FDA approves Medtronic adaptive deep brain stimulation system for Parkinson's Disease NORTHAMPTON, MA / ACCESS Newswire / May 6, 2025 / Liza Bobrow didn't think it was a big deal when her handwriting ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS ...

A former military and commercial pilot is now the first Parkinson’s disease patient in the D.C. area to be using an “adaptive ...